Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2024 Earnings Call Transcript

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2024 Earnings Call Transcript November 6, 2024

Jazz Pharmaceuticals plc beats earnings expectations. Reported EPS is $6.61, expectations were $5.47.

Operator: Ladies and gentlemen. Thank you for standing by. My name is Abbie, and I’ll be your operator today. At this time, I would like to welcome everyone to the Jazz Pharmaceuticals Third Quarter 2024 Earnings Call. All lines have been placed on mute to prevent any background. After the speakers’...